Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications

European Journal of Pharmacology

Volumn 668, Issue 3, 2011, Pages 497-506

  Davidson, Eric P ^b   Coppey, Lawrence J ^b   Holmes, Amey ^a   Dake, Brian ^b   Yorek, Mark A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Angiotensin converting enzyme; Diabetes; Diabetic neuropathy; Neutral endopeptidase; Vascular relaxation; Vasopeptidase inhibitor

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; GLUCOSE; ILEPATRIL; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; GLUCOSE TOLERANCE TEST; HYPOALGESIA; INSULIN RESISTANCE; MALE; NERVE CONDUCTION; NERVE FIBER; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; VASCULAR DISEASE;

ADIPOSE TISSUE; ANIMALS; ARTERIOLES; BLOOD GLUCOSE; BLOOD VESSELS; BODY WEIGHT; CARBOHYDRATE METABOLISM; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUCOSE TOLERANCE TEST; GLUTATHIONE; HETEROCYCLIC COMPOUNDS, 3-RING; INSULIN; LENS, CRYSTALLINE; LEPTIN; MALE; MUSCLE, SKELETAL; NERVE FIBERS; NERVOUS SYSTEM; NOCICEPTION; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SUPEROXIDES; THIOBARBITURATES; TYROSINE; VASODILATION;

EID: 80053573338     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.07.016     Document Type: Article

References (67)

1. Z. Abassi, J. Winaver, and G.Z. Feuerstein The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality Biochem. Pharmacol. 78 2009 933 940
2. K. Araki, T. Masaki, I. Katsuragi, K. Tanaka, T. Kakuma, and H. Yoshimatsu Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice Hypertension 48 2006 51 57 (Pubitemid 44297524)
3. V. Arbin, N. Claperon, M.C. Fournie-Zaluski, B.P. Roques, and J. Peyroux Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats Br. J. Pharmacol. 130 2000 1297 1304 (Pubitemid 30488593)
4. V. Arbin, N. Claperon, M.C. Fournie-Zaluski, B.P. Roques, and J. Peyroux Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor on insulin sensitivity in obese Zucker rat Br. J. Pharmacol. 133 2001 495 502 (Pubitemid 32591915)
5. M. Azizi, A. Bissery, S. Peyrard, T.T. Guyene, M.L. Ozoux, A. Floch, and J. Menard Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans Clin. Pharmacol. Ther. 79 2006 49 61 (Pubitemid 43069578)
6. J.S. Beckman Oxidative damage and tyrosine nitration from peroxynitrite Chem. Res. Toxicol. 9 1996 836 844
7. K.K. Beiswenger, N.A. Calcutt, and A.P. Mizisin Epidermal nerve fiber quantification in the assessment of diabetic neuropathy Acta Histochem. 110 2008 351 362
8. M. Bouskila, M.F. Hirshman, J. Jensen, L.J. Goodyear, and K. Sakamoto Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle Am. J. Physiol. Endocrinol. Metab. 294 2008 E28 E35
9. A. Broccolini, T. Gidaro, R. Morosetti, C. Gliubizzi, T. Servidei, M. Pescatori, P.A. Tonali, E. Ricci, and M. Mirabella Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibers of inclusion body myositis J. Neurochem. 96 2006 777 789
10. Y.M. Cha, M.M. Redfield, S. Shah, W.K. Shen, M.C. Fishbein, and P.S. Chen Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure Heart Rhythm 2 2005 984 990 (Pubitemid 41372288)
11. L.J. Coppey, E.P. Davidson, J. Dunlap, D.D. Lund, and M.A. Yorek Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that provide circulation to the sciatic nerve Int. J. Exp. Diabetes Res. 1 2000 131 143
12. L.J. Coppey, J.S. Gellett, E.P. Davidson, J. Dunlap, D.D. Lund, D. Salvemini, and M.A. Yorek Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular function of epineurial arterioles of the sciatic nerve Br. J. Pharmacol. 134 2001 21 29 (Pubitemid 32835464)
13. L.J. Coppey, J.S. Gellett, E.P. Davidson, J. Dunlap, D.D. Lund, and M.A. Yorek Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve Diabetes 50 2001 1927 1937 (Pubitemid 33641615)
14. L.J. Coppey, J.S. Gellett, E.P. Davidson, J.A. Dunlap, and M.A. Yorek Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve Int. J. Exp. Diabetes Res. 3 2002 21 36 (Pubitemid 35174542)
15. L.J. Coppey, E.P. Davidson, T.W. Rinehart, J.S. Gellett, C.L. Oltman, D.D. Lund, and M.A. Yorek ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats Diabetes 55 2006 341 348 (Pubitemid 43343262)
16. E.P. Davidson, T.L. Kleinschmidt, C.L. Oltman, D.D. Lund, and M.A. Yorek Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor, on vascular and neural disease Diabetes 56 2007 355 362
17. E.P. Davidson, L.J. Coppey, T.L. Kleinschmidt, C.L. Oltman, and M.A. Yorek Vascular and neural dysfunction in obese Zucker rats: effect of AVE7688 Exp. Diabetes Res. 2009 2009 91237
18. E.P. Davidson, L.J. Coppey, N.A. Calcutt, C.L. Oltman, and M.A. Yorek Diet induced obesity in Sprague Dawley rats causes microvascular and neural dysfunction Diabetes Metab. Res. Rev. 26 2010 306 318
19. S.Y. Ding, Z.F. Shen, Y.T. Chen, S.J. Sun, Q. Liu, and M.Z. Xie Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats Acta Pharmacol. Sin. 26 2005 575 580 (Pubitemid 40676168)
20. F. Ebihara, G.S. Di Marco, M.A. Juliano, and D.E. Casarini Neutral endopeptidase expression in mesangial cells J. Renin Angiotensin Aldosterone Syst. 4 228-233 2003 2003
21. R.M. Edwards, M. Pullen, and P. Nambi Distribution of neutral endopeptidase activity along the rat and rabbit nephron Pharmacology 59 1999 45 50 (Pubitemid 29261517)
22. C.M. Ferrario, R.D. Smith, B. Brosnihan, M.C. Chappell, V.M. Campese, O. Vesterqvist, W.C. Liao, M.C. Ruddy, and C.E. Grim Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension Am. J. Hypertens. 15 2002 557 564 (Pubitemid 34596964)
23. D. Finegold, S.A. Lattimer, S. Nolle, M. Bernstein, and D.A. Greene Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy Diabetes 32 1983 988 992 (Pubitemid 14225114)
24. A.B. Gaikwad, B. Viswanad, and P. Ramarao PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance Pharmacol. Res. 55 2007 400 407 (Pubitemid 46584616)
25. W. Gonzalez, J.M. Soleilhac, M.C. Fournie-Zaluski, B.P. Roques, and B.P. Michel Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels Eur. J. Pharmacol. 345 1998 323 331 (Pubitemid 28179575)
26. K. Hanif, H.K. Bid, and R. Konwar Reinventing the ACE inhibitors: some old and new implications of ACE inhibition Hypertens. Res. 33 2010 11 21
27. E.J. Henriksen, and S. Jacob Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats Metabolism 44 1995 267 272
28. E.J. Henriksen, S. Jacob, H.J. Augustin, and G.J. Dietz Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism Diabetes 45 1996 S125 S128
29. A.P. Jayasooriya, M.L. Mathai, L.L. Walker, D.P. Begg, D.A. Denton, D. Cameron-Smith, G.F. Egan, M.J. McKinley, P.D. Rodger, A.J. Sinclair, J.D. Wark, H.S. Weisinger, M. Jois, and R.S. Weisinger Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose tolerance Proc. Natl. Acad. Sci. 105 2008 6531 6536 (Pubitemid 351754541)
30. F. Kikkawa, K. Shibata, T. Suzuki, H. Kajiyama, K. Ino, S. Nomura, and S. Mizutani Signal pathway involved in increased expression of neutral endopeptidase by gonadotropin releasing hormone in choriocarcinoma cells Placenta 25 2004 176 183 (Pubitemid 38248061)
31. R. Kouyama, T. Suganami, J. Nishida, M. Tanaka, T. Toyoda, M. Kiso, T. Chiwata, Y. Miyamoto, Y. Yoshimasa, A. Fukamizu, M. Horiuchi, Y. Hirata, and Y. Ogawa Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor Endocrinology 146 2005 3481 3489 (Pubitemid 41065022)
32. R.A. Malik, S. Williamson, C. Abbott, A.L. Carrington, J. Iqbal, W. Schady, and A.J. Boulton Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomized double-blind controlled trial Lancet 352 1998 1978 1981 (Pubitemid 29000865)
33. K. Miyashita, H. Itoh, H. Tsujimoto, N. Tamura, Y. Fukunaga, M. Sone, K. Yamahara, D. Taura, M. Inuzuka, T. Sonoyama, and K. Nakao Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity Diabetes 58 2009 2880 2892
34. P. Muangman, M.L. Spenny, R.N. Tamura, and N.S. Gibran Fatty acids and glucose increase neutral endopeptidase activity in human microvascular endothelial cells Shock 19 2003 508 512
35. M. Nawano, M. Anai, M. Funaki, H. Kobayashi, A. Kanda, Y. Fukushima, K. Inukai, T. Ogihara, H. Sakoda, Y. Onishi, M. Kikuchi, Y. Yazaki, Y. Oka, and T. Asano Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance Metabolism 48 1999 1248 1255 (Pubitemid 29496071)
36. I.G. Obrosova, F. Li, O.I. Abatan, M.A. Forsell, K. Komjati, P. Pacher, C. Szabo, and M.J. Stevens Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy Diabetes 53 2004 711 720 (Pubitemid 38270641)
37. C.L. Oltman, L.J. Coppey, J.S. Gellett, E.P. Davidson, D.D. Lund, and M.A. Yorek Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty (ZDF) and Zucker rats Am. J. Physiol. Endocrinol. Metab. 289 2005 E113 E122
38. C.L. Oltman, E.P. Davidson, L.J. Coppey, T.L. Kleinschmidt, D.D. Lund, and M.A. Yorek Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin Obesity 16 2008 82 89 (Pubitemid 351271954)
39. C.L. Oltman, E.P. Davidson, L.J. Coppey, T.L. Kleinschmidt, D.D. Lund, and M.A. Yorek Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction Diabetes Obes. Metab. 11 2009 223 233
40. W.A. Pryor, and G.I. Squadrito The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide Am. J. Physiol. 268 1995 L699 L722
41. Q. Pu, and E.L. Schiffrin Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats Am. J. Hypertens. 14 2001 1067 1072 (Pubitemid 32978081)
42. T. Quaschning, L.V. d'Uscio, S. Shaw, H.J. Grone, F. Ruschitzka, and T.F. Luscher Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension J. Am. Soc. Nephrol. 12 2001 2280 2287 (Pubitemid 33021105)
43. M.J. Reed, K. Meszaros, L.J. Entes, M.D. Claypool, J.G. Pinkett, T.M. Gadbois, and G.M. Reaven A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat Metabolism 49 2000 1390 1394
44. A. Reja, S. Tesfaye, N.D. Harris, and U.K. Ward Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabetes Med. 12 1995 307 309
45. J.C. Russell, S.E. Kelly, and S. Schafer Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat J. Cardiovasc. Pharmacol. 44 2004 258 265 (Pubitemid 38982170)
46. E.L. Santos, K. de Picoli Souza, P.B. Guimaraes, F.C. Reis, S.M.S. Silva, C.M. Costa-Neto, J. Luz, and J.B. Pesquero Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats Int. Immunopharmacol. 8 2008 247 253
47. E.L. Santos, K. de Picoli Souza, E.D. da Silva, E.C. Batista, P.J. Martins, V. D'Almeida, and J.B. Pesquero Long term treatment with ACE inhibitor enalapril decreases body weight gain and increased life span in rats Biochem. Pharmacol. 78 2009 951 958
48. S. Schafer, W. Linz, A. Bube, M. Gerl, J. Huber, G.U. Kurzel, M. Bleich, H.-L. Schmidts, A.E. Busch, and H. Rutten Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats Cardiovasc. Res. 60 2003 447 454 (Pubitemid 37412379)
49. S. Schafer, W. Linz, H. Vollert, G. Biemer-Daub, H. Rutten, M. Bleich, and A.E. Busch The vasopeptidase inhibitor AVE7688 ameliorates type 2 diabetic nephropathy Diabetologia 47 2004 98 103 (Pubitemid 38141945)
50. S. Schafer, H.-L. Schmidts, M. Bleich, A.E. Busch, and W. Linz Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent Br. J. Pharmacol. 143 2004 27 32 (Pubitemid 39280021)
51. P. Schling, and T. Schafer Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity J. Biol. Chem. 277 2002 48066 48075 (Pubitemid 35470753)
52. K. Srinivasan, B. Viswanad, L. Asrat, C.L. Kaul, and P. Ramarao Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening Pharmacol. Res. 52 2005 313 320 (Pubitemid 41175991)
53. K. Sugimoto, L. Kazdova, N.R. Qi, M. Hyakukoku, V. Kren, M. Simakova, V. Zidek, T.W. Kurtz, and M. Prevenec Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway J. Hypertens. 26 2008 1209 1215 (Pubitemid 351670512)
54. T. Suzki, K. Ino, F. Kikkawa, C. Uehara, H. Kajiyama, K. Shibata, and S. Mizutani Neutral endopeptidase/CD10 expression during phorbol ester-induced differentiation of choriocarcinoma cells through the protein kinase C- and extracellular signal-regulated kinase-dependent signaling pathway Placenta 23 2002 475 482 (Pubitemid 34975607)
55. M.W. Taal, V.D. Nenov, W. Wong, S.R. Satyal, O. Sakharova, J.H. Choi, J.L. Troy, and B.M. Brenner Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone J. Am. Soc. Nephrol. 12 2001 2051 2059 (Pubitemid 32880341)
56. H. Vatter, L. Schilling, P. Schmiedek, and H. Ehrenreich Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors J. Cardiovasc. Pharmacol. 31 1998 S64 S67
57. C.H. Wang, N. Leung, N. Lapointe, L. Szeto, K.D. Uffelman, A. Giacca, J.L. Rouleau, and G.F. Lewis Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats Circulation 107 2003 1923 1929
58. C. Wang, J. Li, X. Lv, M. Zhang, Y. Song, L. Chen, and Y. Liu Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin Eur. J. Pharmacol. 620 2009 131 137
59. B. Wang, Y. Li, X. Liu, S. Liu, and Sun C. Effect of the duration of high-fat diet and the dosage of streptozotocin on establishing experimental animal model of type 2 diabetes mellitus Wei Sheng Yan Jiu 40 2011 99 102
60. S.K. Wattanapitayakul, D.M. Weinstein, B.J. Holycross, and J.A. Bauer Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders FASEB J. 14 2000 271 278 (Pubitemid 30086064)
61. M. Weber Emerging treatments for hypertension: potential role for vasopeptidase inhibition Am. J. Hypertens. 12 1999 139S 147S
62. R.S. Weisinger, T.K. Stanley, D.P. Begg, H.S. Weisinger, K.J. Spark, and M. Jois Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet Physiol. Behav. 98 2009 192 197
63. V. Wong, L. Szeto, K. Uffelman, I.G. Fantus, and G.F. Lewis Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase J. Endocrinol. 190 2006 441 450 (Pubitemid 44288380)
64. M.A. Yorek The potential role of angiotensin converting enzyme and vasopeptidase inhibitors in the treatment of diabetic neuropathy Curr. Drug Targets 9 2008 77 84 (Pubitemid 351201682)
65. M.A. Yorek, L.J. Coppey, J.S. Gellett, and E.P. Davidson Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes Exp. Diabesity Res. 5 2004 187 193 (Pubitemid 39386566)
66. M. Zhang, X.Y. Lv, J. Li, Z.G. Xu, and L. Chen The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model Exp. Diabetes Res. 704045 2008
67. C. Zhu, H.B. Peng, G.Q. Liu, F. Zhang, and Y. Li Beneficial effects of oligopeptides from marine salmon skin in a rat model of type 2 diabetes Nutrition 26 2010 1014 1020